Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report / 中西医结合学报
Journal of Integrative Medicine
;
(12): 185-190, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-881006
ABSTRACT
After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient's condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Fibrosis Pulmonar
/
Medicamentos Herbarios Chinos
/
Administración Oral
/
Magnoliopsida
/
Exudados y Transudados
/
SARS-CoV-2
/
COVID-19
/
Inflamación
/
Pulmón
/
Medicina Tradicional China
Tipo de estudio:
Estudio diagnóstico
Límite:
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Journal of Integrative Medicine
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS